Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?

Figure 1 Matrix metalloproteinas-2, -7, and -9 plasma levels at the baseline, 3 mo, 12 mo, and 24 mo after gastric bypass and sleeve gastrectomy. A: Matrix metalloproteinase (MMP)-2 levels in GB (gastric bypass) group; B: MMP-2 levels in SG (sleeve gastrectomy) group; C: MMP-7 levels in GB group; D: MMP-7 levels in SG group; E: MMP-9 levels of GB; F: MMP-9 levels of SG. M0: The baseline prior to surgery; M3: 3 mo postoperatively; M12: 12 mo postoperatively; M24: 24 mo postoperatively; GB: Gastric bypass; SG: Sleeve gastrectomy.